{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:18:41Z","timestamp":1774959521055,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":78,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["\\u2013 2012\/23652-0"],"award-info":[{"award-number":["\\u2013 2012\/23652-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.clinsp.2024.100350","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T17:19:37Z","timestamp":1713374377000},"page":"100350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["FOXO3a deregulation in uterine smooth muscle tumors"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5607-3039","authenticated-orcid":false,"given":"Thais Gomes","family":"de Almeida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4419-982X","authenticated-orcid":false,"given":"Anamaria Ritti","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9027-8281","authenticated-orcid":false,"given":"Laura Gonzalez","family":"dos Anjos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0774-9404","authenticated-orcid":false,"given":"Jose Maria","family":"Soares Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9097-8528","authenticated-orcid":false,"given":"Gustavo Arantes Rosa","family":"Maciel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0111-9030","authenticated-orcid":false,"given":"Edmund Chada","family":"Baracat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7295-678X","authenticated-orcid":false,"given":"Katia Candido","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinsp.2024.100350_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-8900-3_1","article-title":"Introduction to FOXO Biology","volume":"1890","author":"Link","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100350_bib0002","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12943-018-0856-3","article-title":"Critical role of FOXO3a in carcinogenesis","volume":"17","author":"Liu","year":"2018","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100350_bib0003","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1038\/s41467-021-23052-9","article-title":"Disruption of FOXO3a-miRNA feedback inhibition of IGF2\/IGF-1R\/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer","volume":"12","author":"Luo","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100350_bib0004","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1158\/0008-5472.CAN-18-2738","article-title":"AKT as a Therapeutic Target for Cancer","volume":"79","author":"Song","year":"2019","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.clinsp.2024.100350_bib0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.clinsp.2024.100350_bib0006","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1038\/s41388-018-0124-4","article-title":"microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer","volume":"37","author":"Kim","year":"2018","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100350_bib0007","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s11596-014-1368-z","article-title":"miRNA-155 modulates the malignant biological characteristics of NK\/T-cell lymphoma cells by targeting FOXO3a gene","volume":"34","author":"Ji","year":"2014","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"12","key":"10.1016\/j.clinsp.2024.100350_bib0008","doi-asserted-by":"crossref","first-page":"e15797","DOI":"10.1371\/journal.pone.0015797","article-title":"Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a","volume":"5","author":"Lin","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.clinsp.2024.100350_bib0009","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1158\/0008-5472.CAN-21-3371","article-title":"Forkhead Box Transcription Factors: Double-Edged Swords in Cancer","volume":"82","author":"Castaneda","year":"2022","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.clinsp.2024.100350_bib0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/GCO.0000000000000569","article-title":"Mass lesions of the myometrium: interpretation and management of unexpected pathology","volume":"31","author":"Porter","year":"2019","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.clinsp.2024.100350_bib0011","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajog.2015.03.019","article-title":"The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013","volume":"213","author":"Soliman","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100350_bib0012","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1066896920958120","article-title":"Gynecological Sarcomas: Molecular Characteristics, Behavior, and Histology-Driven Therapy","volume":"29","author":"Libertini","year":"2021","journal-title":"Int J Surg Pathol"},{"issue":"3","key":"10.1016\/j.clinsp.2024.100350_bib0013","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.21873\/anticanres.14064","article-title":"Recurrent Uterine Smooth-Muscle Tumors of Uncertain Malignant Potential (STUMP): State of The Art","volume":"40","author":"Rizzo","year":"2020","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.clinsp.2024.100350_bib0014","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijgo.2008.12.008","article-title":"FIGO staging for uterine sarcomas","volume":"104","author":"Prat","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100350_bib0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/ijms19010052","article-title":"Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells","volume":"19","author":"de Almeida","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.clinsp.2024.100350_bib0016","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3390\/cells8111452","article-title":"Let-7 miRNA's Expression Profile and Its Potential Prognostic Role in Uterine Leiomyosarcoma","volume":"8","author":"de Almeida","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100350_bib0017","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1245\/s10434-011-2184-3","article-title":"Prognostication of soft tissue sarcomas based on chromosome 17q gene and protein status: evaluation of TOP2A, HER-2\/neu, and survivin","volume":"19","author":"da Cunha","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100350_bib0018","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-010-1161-z","article-title":"FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer","volume":"129","author":"Habashy","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"26","key":"10.1016\/j.clinsp.2024.100350_bib0019","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1200\/JCO.2016.70.5319","article-title":"Comparative Analysis of Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer According to 2007 and 2013 American Society of Clinical Oncology\/College of American Pathologists Guideline Recommendations","volume":"35","author":"Hanna","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinsp.2024.100350_bib0020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejogrb.2023.06.016","article-title":"Uterine sarcomas: A critical review of the literature","volume":"287","author":"Giannini","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100350_bib0021","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/biolre\/ioy195","article-title":"Molecular differential diagnosis of uterine leiomyomas and leiomyosarcomas","volume":"101","author":"Mas","year":"2019","journal-title":"Biol Reprod"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100350_bib0022","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0002-9378(79)80027-7","article-title":"Morphologic features of prognostic significance in uterine smooth muscle tumors: a review of eighty-four cases","volume":"135","author":"Burns","year":"1979","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clinsp.2024.100350_bib0023","doi-asserted-by":"crossref","first-page":"e2324","DOI":"10.6061\/clinics\/2021\/e2324","article-title":"The mutational repertoire of uterine sarcomas and carcinosarcomas in a Brazilian cohort: A preliminary study","volume":"76","author":"da Costa","year":"2021","journal-title":"Clinics (Sao Paulo)"},{"issue":"3","key":"10.1016\/j.clinsp.2024.100350_bib0024","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s43032-021-00731-y","article-title":"Evaluation of Hedgehog Pathway Inhibitors as a Therapeutic Option for Uterine Leiomyosarcoma Using the Xenograft Model","volume":"29","author":"Garcia","year":"2022","journal-title":"Reprod Sci"},{"issue":"2","key":"10.1016\/j.clinsp.2024.100350_bib0025","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4149\/neo_2020_190517N441","article-title":"MicroRNA-506-3p inhibits proliferation and promotes apoptosis in ovarian cancer cell via targeting SIRT1\/AKT\/FOXO3a signaling pathway","volume":"67","author":"Xia","year":"2020","journal-title":"Neoplasma"},{"issue":"8","key":"10.1016\/j.clinsp.2024.100350_bib0026","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/14740338.2021.1931116","article-title":"Efficacy and safety of CDK4\/6 and PI3K\/AKT\/mTOR inhibitors as second-line treatment in postmenopausal patients with hormone receptor-positive, HER-2-negative metastatic breast cancer: a network meta-analysis","volume":"20","author":"Leung","year":"2021","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100350_bib0027","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41573-020-0088-2","article-title":"Therapeutic strategies targeting FOXO transcription factors","volume":"20","author":"Calissi","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"7281","key":"10.1016\/j.clinsp.2024.100350_bib0028","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","article-title":"TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia","volume":"463","author":"Naka","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.clinsp.2024.100350_bib0029","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1158\/1535-7163.MCT-07-0397","article-title":"Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells","volume":"7","author":"Hui","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100350_bib0030","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.molcel.2007.10.035","article-title":"FOXO3a is activated in response to hypoxic stress and inhibits HIF1-induced apoptosis via regulation of CITED2","volume":"28","author":"Bakker","year":"2007","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100350_bib0031","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12935-023-03090-7","article-title":"Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics","volume":"23","author":"Tabnak","year":"2023","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100350_bib0032","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pathol.2022.11.004","article-title":"The role of HER2 as a therapeutic biomarker in gynaecological malignancy: potential for use beyond uterine serous carcinoma","volume":"55","author":"Talia","year":"2023","journal-title":"Pathology"},{"issue":"3","key":"10.1016\/j.clinsp.2024.100350_bib0033","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00292-022-01064-6","article-title":"Praktisch-diagnostische Aspekte uteriner Leiomyosarkome im Kontext der WHO-Klassifikation 2020 [Practical diagnostic aspects of uterine leiomyosarcoma in the context of the 2020 WHO classification]","volume":"43","author":"Horn","year":"2022","journal-title":"Pathologe"},{"issue":"3","key":"10.1016\/j.clinsp.2024.100350_bib0034","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ygyno.2004.07.041","article-title":"ERBB-2 gene overexpression and amplification in uterine sarcomas","volume":"95","author":"Amant","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.clinsp.2024.100350_bib0035","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrm905","article-title":"Signalling shortcuts: cell-surface receptors in the nucleus?","volume":"3","author":"Wells","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"10.1016\/j.clinsp.2024.100350_bib0036","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2174\/1568026620666200303123102","article-title":"Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors","volume":"20","author":"Sabbah","year":"2020","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.clinsp.2024.100350_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105011","article-title":"The synthesis review of the approved tyrosine kinase inhibitors for anticancer therapy in 2015-2020","volume":"113","author":"Liang","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.clinsp.2024.100350_bib0038","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.abb.2014.06.004","article-title":"Insulin-like modulation of Akt\/FoxO signaling by copper ions is independent of insulin receptor","volume":"558","author":"Hamann","year":"2014","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100350_bib0039","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13048-019-0533-1","article-title":"miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1","volume":"12","author":"Liu","year":"2019","journal-title":"J Ovarian Res"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100350_bib0040","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/jcmm.16107","article-title":"MiR155 modulates vascular calcification by regulating Akt-FOXO3a signalling and apoptosis in vascular smooth muscle cells","volume":"25","author":"Li","year":"2021","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.clinsp.2024.100350_bib0041","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.omto.2019.10.006","article-title":"Exosomes Carrying MicroRNA-155 Target Forkhead Box O3 of Endothelial Cells and Promote Angiogenesis in Gastric Cancer","volume":"15","author":"Zhou","year":"2019","journal-title":"Mol Ther Oncolytics"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593224000279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593224000279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T04:21:53Z","timestamp":1735791713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593224000279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":41,"alternative-id":["S1807593224000279"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2024.100350","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FOXO3a deregulation in uterine smooth muscle tumors","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2024.100350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100350"}}